SITC Cancer Immunotherapy CONNECT - Society for Immunotherapy of Cancer (SITC)

More Annotations

Favourite Annotations

Text

SOCIETY FOR IMMUNOTHERAPY OF CANCER Elite Program for Emerging Leaders in Cancer Immunotherapy. SITC is pleased to announce the reinvigoration of the society’s innovative program designed to foster leadership development, collaborations and scientific exchange among early career investigators who are emerging leaders in the field of cancer immunotherapy: Sparkathon Accelerator: Emerging Leaders Igniting Innovation.

HOME - SITC 2021

REGISTRATION

All official forthcoming registration information will be from "Showcare," sitc@showcare.com, SITC 2021's official registration partner. If you have any questions, please contact the SITC office at events@sitcancer.org or +1 414 271 2456. CERTIFICATE IN CANCER IMMUNOTHERAPY Then, to earn a current certificate, which allows one to continue to use the SITC-G designation, an individual will need to take and pass updated coursework and assessments. If one misses the deadline for reissuance, he or she will need to retake and pass the full program. SITC Graduate in Cancer Immunotherapy / SITC-G. SITC Member Price:

$25.00.

HOME - SITC 2021

REGISTRATION

All official forthcoming registration information will be from "Showcare," sitc@showcare.com, SITC 2021's official registration partner. If you have any questions, please contact the SITC office at events@sitcancer.org or +1 414 271 2456. CERTIFICATE IN CANCER IMMUNOTHERAPY Then, to earn a current certificate, which allows one to continue to use the SITC-G designation, an individual will need to take and pass updated coursework and assessments. If one misses the deadline for reissuance, he or she will need to retake and pass the full program. SITC Graduate in Cancer Immunotherapy / SITC-G. SITC Member Price:

$25.00.

GUIDELINES AND POLICIES Agree to release of the abstract title prior to the SITC embargo date and time of 8 a.m. EST on Nov. 9, 2021. Regular abstract titles will be released at 8 a.m. EST on Oct. 1, 2021 and late-breaking abstract titles will be releases at 8 a.m. EST on Nov. 1, 2021. Agree to follow all media and press release policies set forth by SITC. THE CHECKPOINTS PARTY Wear your CheckPoints t-shirt and join your favorite rockstar scientists for the highly anticipated return of The CheckPoints, the house band of the Society for Immunotherapy of Cancer (SITC), to the 36th Annual Meeting (SITC 2021) is scheduled for 8:30–10:30 p.m. EST on Saturday, Nov.13, 2021. Comprised of SITC members who are luminaries in the field of cancer immunotherapy, The CheckPoints 36TH ANNUAL MEETING & PRE-CONFERENCE PROGRAMS (SITC 2021 The Society for Immunotherapy of Cancer’s (SITC) 36 th Annual Meeting & Pre-Conference Programs (SITC 2021) will take place on Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington, D.C. Registration and other details will be announced soon! Thank You to Our Organizers Annual Program Committee CHAIR BISPECIFIC T CELL ENGAGERS WORKSHOP Immediately preceding the Bispecific T cell Engagers Workshop, SITC is hosting an innovative workshop, Interrogating the Tumor-Specific Surfaceome for Immune Targeting, focused on the tumor cell surfaceome and the many opportunities that accompany it for the development of future immunotherapies and maximization of existing techniques. A collaborative session, taking place the HOME - SITC 2019 - SITCANCER.ORG About SITC 2019. The Society for Immunotherapy of Cancer (SITC) welcomed delegates to the 34 th Annual Meeting & Pre-Conference Programs (SITC 2019) on Nov. 6–10, 2019, held at the Gaylord National Hotel & Convention Center in National Harbor, Md.. The Annual Meeting & Pre-Conference Programs is the leading destination for scientific exchange, education and networking in the cancer SITC MEMBERSHIP CATEGORIES SITC offers a variety of membership categories including regular membership, affiliate membership, allied health membership, emeritus membership, nurse and advanced practice provider membership, patient membership and student membership. GUIDELINES AND POLICIES Agree to release of the abstract title prior to the SITC embargo date and time of 8 a.m. EST on Nov. 9, 2021. Regular abstract titles will be released at 8 a.m. EST on Oct. 1, 2021 and late-breaking abstract titles will be releases at 8 a.m. EST on Nov. 1, 2021. Agree to follow all media and press release policies set forth by SITC. SITC STATEMENT ON SARS-COV-2 VACCINATION AND CANCER MILWAUKEE – The Society for Immunotherapy of Cancer (SITC) commends the global biomedical community for coming together to develop and authorize safe and effective SARS-CoV-2 vaccines at unprecedented speeds. SITC stands with the world in hoping that rapid vaccine deployment will help to end the global pandemic. Representing leaders in the field of cancer immunotherapy, SITC CERTIFICATE IN CANCER IMMUNOTHERAPY Then, to earn a current certificate, which allows one to continue to use the SITC-G designation, an individual will need to take and pass updated coursework and assessments. If one misses the deadline for reissuance, he or she will need to retake and pass the full program. SITC Graduate in Cancer Immunotherapy / SITC-G. SITC Member Price:

$25.00.

UPCOMING EVENTS

Upcoming events calendar of the Society for Immunotherapy of Cancer (SITC), including the Annual Meeting & Pre-Conference Programs, Advances in Cancer Immunotherapy™ regional education programs, webinars, webcasts and more. SITC ANNUAL MEETING & PRE-CONFERENCE PROGRAMS The Society for Immunotherapy of Cancer (SITC) Annual Meeting & Pre-Conference Programs brings together stakeholders across the cancer immunotherapy field to advance the science, discover breakthroughs and educate the world on cancer immunotherapy. As the largest conference solely focused on cancer immunotherapy, the Annual Meeting & Pre-Conference Programs provides

VIRTUAL HAPPY HOUR

Moderated by Early Career Scientist Committee members, SITC’s Professional Interest Community (PIC) Virtual Happy Hours are free, evening digital networking events which will be held on a monthly basis and allow for young investigators and junior faculty to gather and discuss important issues related to the field. Discussion topics and guest speakers for future virtual happy hour sessions ANNUAL MEETING • NOV. 12–14, 2021 The Society for Immunotherapy of Cancer (SITC) Annual Meeting & Pre-Conference Programs (SITC 2021) brings together stakeholders across the cancer immunotherapy field to work towards improving cancer patient outcomes by advancing the science, discovering breakthroughs and educating the world on cancer immunotherapy. The conference includes cutting-edge research presented by experts in the THE SENTINEL: JUNE 2021 Dear Colleagues, Before I announce this month’s fireside chat companion, I wanted to make sure you all have had the opportunity to view the recently published diversity panel discussion on barriers to Asians and Pacific Islanders in medicine and research.This program, conducted in collaboration with the Chinese American Hematologic and Oncologist Network (CAHON) and the Indo-American Cancer SOCIETY FOR IMMUNOTHERAPY OF CANCER Elite Program for Emerging Leaders in Cancer Immunotherapy. SITC is pleased to announce the reinvigoration of the society’s unique program designed to foster leadership development, collaborations and scientific exchange among early career investigators who are emerging leaders in the field of cancer immunotherapy: Sparkathon Accelerator: Emerging Leaders Igniting Innovation.

HOME - SITC 2021

REGISTRATION

All official forthcoming registration information will be from "Showcare," sitc@showcare.com, SITC 2021's official registration partner. If you have any questions, please contact the SITC office at events@sitcancer.org or +1 414 271 2456. SITC ANNUAL MEETING & PRE-CONFERENCE PROGRAMS The Society for Immunotherapy of Cancer (SITC) Annual Meeting & Pre-Conference Programs brings together stakeholders across the cancer immunotherapy field to advance the science, discover breakthroughs and educate the world on cancer immunotherapy. As the largest conference solely focused on cancer immunotherapy, the Annual Meeting & Pre-Conference Programs provides GUIDELINES AND POLICIES Agree to release of the abstract title prior to the SITC embargo date and time of 8 a.m. EST on Nov. 9, 2021. Regular abstract titles will be released at 8 a.m. EST on Oct. 1, 2021 and late-breaking abstract titles will be releases at 8 a.m. EST on Nov. 1, 2021. Agree to follow all media and press release policies set forth by SITC. 36TH ANNUAL MEETING & PRE-CONFERENCE PROGRAMS (SITC 2021 The Society for Immunotherapy of Cancer’s (SITC) 36 th Annual Meeting & Pre-Conference Programs (SITC 2021) will take place on Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington, D.C. Registration and other details will be announced soon! Thank You to Our Organizers Annual Program Committee CHAIR THE CHECKPOINTS PARTY Wear your CheckPoints t-shirt and join your favorite rockstar scientists for the highly anticipated return of The CheckPoints, the house band of the Society for Immunotherapy of Cancer (SITC), to the 36th Annual Meeting (SITC 2021) is scheduled for 8:30–10:30 p.m. EST on Saturday, Nov.13, 2021. Comprised of SITC members who are luminaries in the field of cancer immunotherapy, The CheckPoints BISPECIFIC T CELL ENGAGERS WORKSHOP Immediately preceding the Bispecific T cell Engagers Workshop, SITC is hosting an innovative workshop, Interrogating the Tumor-Specific Surfaceome for Immune Targeting, focused on the tumor cell surfaceome and the many opportunities that accompany it for the development of future immunotherapies and maximization of existing techniques. A collaborative session, taking place the SOCIETY FOR IMMUNOTHERAPY OF CANCER Elite Program for Emerging Leaders in Cancer Immunotherapy. SITC is pleased to announce the reinvigoration of the society’s unique program designed to foster leadership development, collaborations and scientific exchange among early career investigators who are emerging leaders in the field of cancer immunotherapy: Sparkathon Accelerator: Emerging Leaders Igniting Innovation.

HOME - SITC 2021

REGISTRATION

All official forthcoming registration information will be from "Showcare," sitc@showcare.com, SITC 2021's official registration partner. If you have any questions, please contact the SITC office at events@sitcancer.org or +1 414 271 2456. SITC ANNUAL MEETING & PRE-CONFERENCE PROGRAMS The Society for Immunotherapy of Cancer (SITC) Annual Meeting & Pre-Conference Programs brings together stakeholders across the cancer immunotherapy field to advance the science, discover breakthroughs and educate the world on cancer immunotherapy. As the largest conference solely focused on cancer immunotherapy, the Annual Meeting & Pre-Conference Programs provides GUIDELINES AND POLICIES Agree to release of the abstract title prior to the SITC embargo date and time of 8 a.m. EST on Nov. 9, 2021. Regular abstract titles will be released at 8 a.m. EST on Oct. 1, 2021 and late-breaking abstract titles will be releases at 8 a.m. EST on Nov. 1, 2021. Agree to follow all media and press release policies set forth by SITC. 36TH ANNUAL MEETING & PRE-CONFERENCE PROGRAMS (SITC 2021 The Society for Immunotherapy of Cancer’s (SITC) 36 th Annual Meeting & Pre-Conference Programs (SITC 2021) will take place on Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington, D.C. Registration and other details will be announced soon! Thank You to Our Organizers Annual Program Committee CHAIR THE CHECKPOINTS PARTY Wear your CheckPoints t-shirt and join your favorite rockstar scientists for the highly anticipated return of The CheckPoints, the house band of the Society for Immunotherapy of Cancer (SITC), to the 36th Annual Meeting (SITC 2021) is scheduled for 8:30–10:30 p.m. EST on Saturday, Nov.13, 2021. Comprised of SITC members who are luminaries in the field of cancer immunotherapy, The CheckPoints BISPECIFIC T CELL ENGAGERS WORKSHOP Immediately preceding the Bispecific T cell Engagers Workshop, SITC is hosting an innovative workshop, Interrogating the Tumor-Specific Surfaceome for Immune Targeting, focused on the tumor cell surfaceome and the many opportunities that accompany it for the development of future immunotherapies and maximization of existing techniques. A collaborative session, taking place the HOME - SITC 2019 - SITCANCER.ORG About SITC 2019. The Society for Immunotherapy of Cancer (SITC) welcomed delegates to the 34 th Annual Meeting & Pre-Conference Programs (SITC 2019) on Nov. 6–10, 2019, held at the Gaylord National Hotel & Convention Center in National Harbor, Md.. The Annual Meeting & Pre-Conference Programs is the leading destination for scientific exchange, education and networking in the cancer SITC STATEMENT ON SARS-COV-2 VACCINATION AND CANCER MILWAUKEE – The Society for Immunotherapy of Cancer (SITC) commends the global biomedical community for coming together to develop and authorize safe and effective SARS-CoV-2 vaccines at unprecedented speeds. SITC stands with the world in hoping that rapid vaccine deployment will help to end the global pandemic. Representing leaders in the field of cancer immunotherapy, SITC SITC MEMBERSHIP CATEGORIES SITC offers a variety of membership categories including regular membership, affiliate membership, allied health membership, emeritus membership, nurse and advanced practice provider membership, patient membership and student membership. GUIDELINES AND POLICIES Agree to release of the abstract title prior to the SITC embargo date and time of 8 a.m. EST on Nov. 9, 2021. Regular abstract titles will be released at 8 a.m. EST on Oct. 1, 2021 and late-breaking abstract titles will be releases at 8 a.m. EST on Nov. 1, 2021. Agree to follow all media and press release policies set forth by SITC.

UPCOMING EVENTS

Upcoming events calendar of the Society for Immunotherapy of Cancer (SITC), including the Annual Meeting & Pre-Conference Programs, Advances in Cancer Immunotherapy™ regional education programs, webinars, webcasts and more. SITC CANCER IMMUNOTHERAPY GUIDELINES The SITC Cancer Immunotherapy Guidelines program is a collection of Clinical Practice Guidelines (CPGs) developed by multi-disciplinary panels of experts who draw from their own practical experience as well as evidence in the published literature and clinical trial data to develop evidence- and consensus-based recommendations on when and how to use immunotherapy to help improve

the Society.

UPCOMING WEBINARS

555 East Wells Street, Suite 1100 | Milwaukee, WI | 53202-3823 | USA THE SENTINEL: JUNE 2021 Dear Colleagues, Before I announce this month’s fireside chat companion, I wanted to make sure you all have had the opportunity to view the recently published diversity panel discussion on barriers to Asians and Pacific Islanders in medicine and research.This program, conducted in collaboration with the Chinese American Hematologic and Oncologist Network (CAHON) and the Indo-American Cancer RENAL CELL CARCINOMA The Society for Immunotherapy of Cancer (SITC) published it's first clinical practice guideline (CPG) on immunotherapy for the treatment of Renal Cell Carcinoma in the Journal for ImmunoTherapy of Cancer on November 15, 2016. With the many advancements in immuno-oncology for the treatment of renal cell carcinoma, the SITC Renal Cell Carcinoma expert panel reconvened, SOCIETY FOR IMMUNOTHERAPY OF CANCER Elite Program for Emerging Leaders in Cancer Immunotherapy. SITC is pleased to announce the reinvigoration of the society’s unique program designed to foster leadership development, collaborations and scientific exchange among early career investigators who are emerging leaders in the field of cancer immunotherapy: Sparkathon Accelerator: Emerging Leaders Igniting Innovation.

HOME - SITC 2021

REGISTRATION

All official forthcoming registration information will be from "Showcare," sitc@showcare.com, SITC 2021's official registration partner. If you have any questions, please contact the SITC office at events@sitcancer.org or +1 414 271 2456. SITC ANNUAL MEETING & PRE-CONFERENCE PROGRAMS The Society for Immunotherapy of Cancer (SITC) Annual Meeting & Pre-Conference Programs brings together stakeholders across the cancer immunotherapy field to advance the science, discover breakthroughs and educate the world on cancer immunotherapy. As the largest conference solely focused on cancer immunotherapy, the Annual Meeting & Pre-Conference Programs provides GUIDELINES AND POLICIES Agree to release of the abstract title prior to the SITC embargo date and time of 8 a.m. EST on Nov. 9, 2021. Regular abstract titles will be released at 8 a.m. EST on Oct. 1, 2021 and late-breaking abstract titles will be releases at 8 a.m. EST on Nov. 1, 2021. Agree to follow all media and press release policies set forth by SITC. 36TH ANNUAL MEETING & PRE-CONFERENCE PROGRAMS (SITC 2021 The Society for Immunotherapy of Cancer’s (SITC) 36 th Annual Meeting & Pre-Conference Programs (SITC 2021) will take place on Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington, D.C. Registration and other details will be announced soon! Thank You to Our Organizers Annual Program Committee CHAIR THE CHECKPOINTS PARTY Wear your CheckPoints t-shirt and join your favorite rockstar scientists for the highly anticipated return of The CheckPoints, the house band of the Society for Immunotherapy of Cancer (SITC), to the 36th Annual Meeting (SITC 2021) is scheduled for 8:30–10:30 p.m. EST on Saturday, Nov.13, 2021. Comprised of SITC members who are luminaries in the field of cancer immunotherapy, The CheckPoints BISPECIFIC T CELL ENGAGERS WORKSHOP Immediately preceding the Bispecific T cell Engagers Workshop, SITC is hosting an innovative workshop, Interrogating the Tumor-Specific Surfaceome for Immune Targeting, focused on the tumor cell surfaceome and the many opportunities that accompany it for the development of future immunotherapies and maximization of existing techniques. A collaborative session, taking place the SOCIETY FOR IMMUNOTHERAPY OF CANCER Elite Program for Emerging Leaders in Cancer Immunotherapy. SITC is pleased to announce the reinvigoration of the society’s unique program designed to foster leadership development, collaborations and scientific exchange among early career investigators who are emerging leaders in the field of cancer immunotherapy: Sparkathon Accelerator: Emerging Leaders Igniting Innovation.

HOME - SITC 2021

REGISTRATION

All official forthcoming registration information will be from "Showcare," sitc@showcare.com, SITC 2021's official registration partner. If you have any questions, please contact the SITC office at events@sitcancer.org or +1 414 271 2456. SITC ANNUAL MEETING & PRE-CONFERENCE PROGRAMS The Society for Immunotherapy of Cancer (SITC) Annual Meeting & Pre-Conference Programs brings together stakeholders across the cancer immunotherapy field to advance the science, discover breakthroughs and educate the world on cancer immunotherapy. As the largest conference solely focused on cancer immunotherapy, the Annual Meeting & Pre-Conference Programs provides GUIDELINES AND POLICIES Agree to release of the abstract title prior to the SITC embargo date and time of 8 a.m. EST on Nov. 9, 2021. Regular abstract titles will be released at 8 a.m. EST on Oct. 1, 2021 and late-breaking abstract titles will be releases at 8 a.m. EST on Nov. 1, 2021. Agree to follow all media and press release policies set forth by SITC. 36TH ANNUAL MEETING & PRE-CONFERENCE PROGRAMS (SITC 2021 The Society for Immunotherapy of Cancer’s (SITC) 36 th Annual Meeting & Pre-Conference Programs (SITC 2021) will take place on Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington, D.C. Registration and other details will be announced soon! Thank You to Our Organizers Annual Program Committee CHAIR THE CHECKPOINTS PARTY Wear your CheckPoints t-shirt and join your favorite rockstar scientists for the highly anticipated return of The CheckPoints, the house band of the Society for Immunotherapy of Cancer (SITC), to the 36th Annual Meeting (SITC 2021) is scheduled for 8:30–10:30 p.m. EST on Saturday, Nov.13, 2021. Comprised of SITC members who are luminaries in the field of cancer immunotherapy, The CheckPoints BISPECIFIC T CELL ENGAGERS WORKSHOP Immediately preceding the Bispecific T cell Engagers Workshop, SITC is hosting an innovative workshop, Interrogating the Tumor-Specific Surfaceome for Immune Targeting, focused on the tumor cell surfaceome and the many opportunities that accompany it for the development of future immunotherapies and maximization of existing techniques. A collaborative session, taking place the HOME - SITC 2019 - SITCANCER.ORG About SITC 2019. The Society for Immunotherapy of Cancer (SITC) welcomed delegates to the 34 th Annual Meeting & Pre-Conference Programs (SITC 2019) on Nov. 6–10, 2019, held at the Gaylord National Hotel & Convention Center in National Harbor, Md.. The Annual Meeting & Pre-Conference Programs is the leading destination for scientific exchange, education and networking in the cancer SITC STATEMENT ON SARS-COV-2 VACCINATION AND CANCER MILWAUKEE – The Society for Immunotherapy of Cancer (SITC) commends the global biomedical community for coming together to develop and authorize safe and effective SARS-CoV-2 vaccines at unprecedented speeds. SITC stands with the world in hoping that rapid vaccine deployment will help to end the global pandemic. Representing leaders in the field of cancer immunotherapy, SITC SITC MEMBERSHIP CATEGORIES SITC offers a variety of membership categories including regular membership, affiliate membership, allied health membership, emeritus membership, nurse and advanced practice provider membership, patient membership and student membership. GUIDELINES AND POLICIES Agree to release of the abstract title prior to the SITC embargo date and time of 8 a.m. EST on Nov. 9, 2021. Regular abstract titles will be released at 8 a.m. EST on Oct. 1, 2021 and late-breaking abstract titles will be releases at 8 a.m. EST on Nov. 1, 2021. Agree to follow all media and press release policies set forth by SITC.

UPCOMING EVENTS

Upcoming events calendar of the Society for Immunotherapy of Cancer (SITC), including the Annual Meeting & Pre-Conference Programs, Advances in Cancer Immunotherapy™ regional education programs, webinars, webcasts and more. SITC CANCER IMMUNOTHERAPY GUIDELINES The SITC Cancer Immunotherapy Guidelines program is a collection of Clinical Practice Guidelines (CPGs) developed by multi-disciplinary panels of experts who draw from their own practical experience as well as evidence in the published literature and clinical trial data to develop evidence- and consensus-based recommendations on when and how to use immunotherapy to help improve

the Society.

UPCOMING WEBINARS

HOME - SITC 2021

REGISTRATION

SITC 2018

IRAES: IMMUNE RELATED ADVERSE EVENTS MANAGEMENT AND MITIGATION The Five Pillars of Immunotherapy Toxicity Management Champiat Ann Oncol 2016;27:559-574 Know Toxicity Spectrum Educate Patients Always

consider

SOCIETY FOR IMMUNOTHERAPY OF CANCER Elite Program for Emerging Leaders in Cancer Immunotherapy. SITC is pleased to announce the reinvigoration of the society’s unique program designed to foster leadership development, collaborations and scientific exchange among early career investigators who are emerging leaders in the field of cancer immunotherapy: Sparkathon Accelerator: Emerging Leaders Igniting Innovation.

HOME - SITC 2021

REGISTRATION

SITC 2018

IRAES: IMMUNE RELATED ADVERSE EVENTS MANAGEMENT AND MITIGATION The Five Pillars of Immunotherapy Toxicity Management Champiat Ann Oncol 2016;27:559-574 Know Toxicity Spectrum Educate Patients Always

consider

EXHIBITOR INFORMATION Make your mark by exhibiting at the Society for Immunotherapy of Cancer's 36 th Annual Meeting & Pre-Conference Programs (SITC 2021) - now a hybrid experience!. SITC 2021 will feature hybrid virtual exhibit opportunities! The “What’s New in IO” Hall will feature in-person booths, sponsored presentations, poster walks, and more, all supplemented by virtual components. ANNUAL MEETING • NOV. 12–14, 2021 The Society for Immunotherapy of Cancer (SITC) Annual Meeting & Pre-Conference Programs (SITC 2021) brings together stakeholders across the cancer immunotherapy field to work towards improving cancer patient outcomes by advancing the science, discovering breakthroughs and educating the world on cancer immunotherapy. The conference includes cutting-edge research presented by experts in the SITC STATEMENT ON SARS-COV-2 VACCINATION AND CANCER MILWAUKEE – The Society for Immunotherapy of Cancer (SITC) commends the global biomedical community for coming together to develop and authorize safe and effective SARS-CoV-2 vaccines at unprecedented speeds. SITC stands with the world in hoping that rapid vaccine deployment will help to end the global pandemic. Representing leaders in the field of cancer immunotherapy, SITC CERTIFICATE IN CANCER IMMUNOTHERAPY Then, to earn a current certificate, which allows one to continue to use the SITC-G designation, an individual will need to take and pass updated coursework and assessments. If one misses the deadline for reissuance, he or she will need to retake and pass the full program. SITC Graduate in Cancer Immunotherapy / SITC-G. SITC Member Price:

$25.00.

SITC CPG WEBINAR

On Monday, June 21, 2021 from 4 – 5 pm ET, join leading experts from the SITC Lymphoma Immunotherapy Guideline Expert Panel for the "SITC Clinical Practice Guideline Webinar – Practical Management Pearls for Immunotherapy for the Treatment of Lymphoma." SITC CANCER IMMUNOTHERAPY GUIDELINES The SITC Cancer Immunotherapy Guidelines program is a collection of Clinical Practice Guidelines (CPGs) developed by multi-disciplinary panels of experts who draw from their own practical experience as well as evidence in the published literature and clinical trial data to develop evidence- and consensus-based recommendations on when and how to use immunotherapy to help improve

the Society.

ADVANCES IN CANCER IMMUNOTHERAPY™️ WEBINAR: CLINICAL On July 16, 2021 at 12:00 pm ET, join Paolo A. Ascierto, MD and other leading experts in cancer imm THE SENTINEL: JUNE 2021 Dear Colleagues, Before I announce this month’s fireside chat companion, I wanted to make sure you all have had the opportunity to view the recently published diversity panel discussion on barriers to Asians and Pacific Islanders in medicine and research.This program, conducted in collaboration with the Chinese American Hematologic and Oncologist Network (CAHON) and the Indo-American Cancer SOCIETY FOR IMMUNOTHERAPY OF CANCER Elite Program for Emerging Leaders in Cancer Immunotherapy. SITC is pleased to announce the reinvigoration of the society’s unique program designed to foster leadership development, collaborations and scientific exchange among early career investigators who are emerging leaders in the field of cancer immunotherapy: Sparkathon Accelerator: Emerging Leaders Igniting Innovation.

HOME - SITC 2021

The Society for Immunotherapy of Cancer (SITC) Annual Meeting & Pre-Conference Programs (SITC 2021) brings together stakeholders across the cancer immunotherapy field to work towards improving cancer patient outcomes by advancing the science, discovering breakthroughs and educating the world on cancer immunotherapy. The conference includes cutting-edge research presented by experts in the HOME - SITC 2020 - SITCANCER.ORG The Society for Immunotherapy of Cancer’s (SITC) 35th Anniversary Annual Meeting & Pre-Conference Programs (SITC 2020) will be reimagined as a fully VIRTUAL experience this year to ensure the health and safety of program attendees and their patients, and in celebration of the society’s 35th anniversary, all SITC members are invited to register for FREE! ABSTRACT INFORMATION The Society for Immunotherapy of Cancer (SITC) will begin accepting submissions of regular abstracts and late-breaking abstract applications for the 36th Anniversary Annual Meeting (SITC 2021) beginning on April 1, 2020. The deadline to submit research for a regular abstract, Young Investigator Award abstract and/or late-breaking abstract application is 5 p.m. PDT on July 31, 2020. ANNUAL MEETING • NOV. 12–14, 2021 The Society for Immunotherapy of Cancer (SITC) Annual Meeting & Pre-Conference Programs (SITC 2021) brings together stakeholders across the cancer immunotherapy field to work towards improving cancer patient outcomes by advancing the science, discovering breakthroughs and educating the world on cancer immunotherapy. The conference includes cutting-edge research presented by experts in the 36TH ANNUAL MEETING & PRE-CONFERENCE PROGRAMS (SITC 2021 The Society for Immunotherapy of Cancer’s (SITC) 36 th Annual Meeting & Pre-Conference Programs (SITC 2021) will take place on Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington, D.C. Registration and other details will be announced soon! Thank You to Our Organizers Annual Program Committee CHAIR SITC CANCER IMMUNOTHERAPY GUIDELINES The SITC Cancer Immunotherapy Guidelines program is a collection of Clinical Practice Guidelines (CPGs) developed by multi-disciplinary panels of experts who draw from their own practical experience as well as evidence in the published literature and clinical trial data to develop evidence- and consensus-based recommendations on when and how to use immunotherapy to help improve

UPCOMING WEBINARS

HOME - SITC 2021

UPCOMING WEBINARS

555 East Wells Street, Suite 1100 | Milwaukee, WI | 53202-3823 | USA THE CHECKPOINTS PARTY Wear your CheckPoints t-shirt and join your favorite rockstar scientists for the highly anticipated return of The CheckPoints, the house band of the Society for Immunotherapy of Cancer (SITC), to the 36th Annual Meeting (SITC 2021) is scheduled for 8:30–10:30 p.m. EST on Saturday, Nov.13, 2021. Comprised of SITC members who are luminaries in the field of cancer immunotherapy, The CheckPoints 2020 TEAM SCIENCE AWARDEES 2020 Team Science Awardees. This award recognizes teams of scientists that have made a long-standing contribution to the field to cancer immunotherapy over the past 35 years. The teams and individuals listed below were honored as part of SITC's 35th Anniversary Annual Meeting. SOCIETY FOR IMMUNOTHERAPY OF CANCER Elite Program for Emerging Leaders in Cancer Immunotherapy. SITC is pleased to announce the reinvigoration of the society’s unique program designed to foster leadership development, collaborations and scientific exchange among early career investigators who are emerging leaders in the field of cancer immunotherapy: Sparkathon Accelerator: Emerging Leaders Igniting Innovation. HOME - SITC 2019 - SITCANCER.ORG About SITC 2019. The Society for Immunotherapy of Cancer (SITC) welcomed delegates to the 34 th Annual Meeting & Pre-Conference Programs (SITC 2019) on Nov. 6–10, 2019, held at the Gaylord National Hotel & Convention Center in National Harbor, Md.. The Annual Meeting & Pre-Conference Programs is the leading destination for scientific exchange, education and networking in the cancer SITC ANNUAL MEETING & PRE-CONFERENCE PROGRAMS The Society for Immunotherapy of Cancer (SITC) Annual Meeting & Pre-Conference Programs brings together stakeholders across the cancer immunotherapy field to advance the science, discover breakthroughs and educate the world on cancer immunotherapy. As the largest conference solely focused on cancer immunotherapy, the Annual Meeting & Pre-Conference Programs provides EXHIBITOR INFORMATION Make your mark by exhibiting at the Society for Immunotherapy of Cancer's 36 th Annual Meeting & Pre-Conference Programs (SITC 2021) - now a hybrid experience!. SITC 2021 will feature hybrid virtual exhibit opportunities! The “What’s New in IO” Hall will feature in-person booths, sponsored presentations, poster walks, and more, all supplemented by virtual components.

GENERAL INFORMATION

Exhibit at SITC. Make your mark at the largest cancer immunotherapy conference and host an exhibit at SITC's 36 th Annual Meeting. The “What’s New in IO” Hall will feature company booths, posters, sponsored presentations, and more. CME/CE FOR ESMO IO 2020 WEBINAR The 2020-2021 Advances in Cancer Immunotherapy™ series is brought to you in collaboration with the American Academy of Emergency Medicine, the Association of Community Cancer Centers and the Hematology/Oncology Pharmacy Association. The 2020–2021 Advances in Cancer Immunotherapy™ educational series is supported, in part, by independent medical education grants from Amgen, FOCIS 2021 VIRTUAL ANNUAL MEETING This website uses cookies to deliver to you the best experience possible on SITC CONNECT. By continuing to use this site, you are providing to us your consent to ensure you receive such an experience. 2021 FOCIS-SITC CANCER IMMUNITY AND IMMUNOTHERAPY COURSE Presented by the Federation of Clinical Immunology Societies (FOCIS) and the Society for Immunotherapy of Cancer (SITC) The course, Cancer Immunity & Immunotherapy, will review tumor immunology as the scientific foundation for the current practice of cancer immunotherapy, emphasizing fundamental principles, clinical advances, limitations, and opportunities to accelerate clinical program. THE SENTINEL: JUNE 2021 Dear Colleagues, Before I announce this month’s fireside chat companion, I wanted to make sure you all have had the opportunity to view the recently published diversity panel discussion on barriers to Asians and Pacific Islanders in medicine and research.This program, conducted in collaboration with the Chinese American Hematologic and Oncologist Network (CAHON) and the Indo-American Cancer ADVANCES IN CANCER IMMUNOTHERAPY™️ WEBINAR: CLINICAL On July 16, 2021 at 12:00 pm ET, join Paolo A. Ascierto, MD and other leading experts in cancer imm This website uses cookies to deliver to you the best experience possible on SITC CONNECT. By continuing to use this site, you are providing to us your consent to ensure you receive such an experience. View our privacy policy to learn more.

OK

JOIN OR RENEW TODAY: SITC 2021 MEMBERSHIP NOW OPEN Skip to main content (Press Enter).

Sign in

*

Announcements

Blogs

Communities

Discussions

Events

Glossary

Site Content

Libraries

on this day between these dates

Not a valid date

Posted by

Skip auxiliary navigation (Press Enter).

* Subscribe

Skip main navigation (Press Enter).

Toggle navigation

* The Connect Community

* Create Account

* My Profile

* My Communities

* My Libraries

* Member Directory

* Open Forum

* About SITC CONNECT * The Sentinel - SITC Blog * Education & Scientific Exchange * SITC Cancer Immunotherapy connectED * Annual Meeting & Pre-Conference Programs

* Archive

* SITC17 Webcast Continuing Education * Advances in Cancer Immunotherapy™

* Online

* 2016 Advances in Cancer Immunotherapy™ Program Archive * Advances in Cancer Immunotherapy™

* Online

* 2016 Advances in Cancer Immunotherapy™ Program Archive

* CME/CE

* Registration

* Webcast Registration * Enduring Materials

* 2016

* 2018

* Charleston, SC - 2.24 * 2019-2020 Continuing Education Information * CME/CE for ASCO 2020 Webinar * CME/CE for SITC 2019 Webinar * CME/CE for ESMO Immuno Oncology Congress 2019 Webinar * 2020-2021 Continuing Education Information

* Registration

* Program Purpose

* Webcast Registration * Enduring Materials

* 2016

* 2018-2019

* Madison, Wis. - 9/6 Webcast * Madison, Wis. - 9/6 * Boston, Mass. - 9/27 * Indianapolis, Ind. - 10/25 * Minneapolis, Minn. - TBD * New York City, N.Y. - 11/15 * Louisville, Ky. - 12/6 * Pittsburgh, Penn. - 12/15 * Sacramento, Calif. - 1/10 * New Orleans, La. - 4/6/19 * Houston, Texas - 2/9 * Portland, Ore - 2/21

* Denver, Co. - TBD

* Salt Lake City, Utah - TBD * Toronto, Ont. - TBD * Seattle, Wash. - 11/3 * ACI Planning Committee

* 2019-2020

* Charleston, S.C.

* Boston, Mass.

* Buffalo, N.Y.

* Charlotte, N.C.

* Chicago, Ill.

* Cleveland, Ohio

* Nashville, Tenn.

* Philadelphia, Pa.

* San Diego, Calif.

* San Francisco, Calif.

* Tucson, Ariz.

* Seattle

* Washington, D.C.

* Toronto

* Nashville, Tenn. - Webcast

* 2020-2021

* San Antonio

* Boston

* Madison

* Pittsburgh

* New Haven

* Louisville

* Indianapolis

* Cancer Immunotherapy Winter School

* Travel Awards

* Andy Kah Ping Tay, PhD

* Ravi Patel, PhD

* Izak Faiena, MD

* Julie Collins, MD, MPH * Namrata Chandhok, MD

* Registration

* Surfaceome Workshop * Cytokines in Cancer Immunotherapy Workshop * Cytokines in Cancer Immunotherapy Workshop Schedule * Registration Rates * Cancer Immune Responsiveness Workshop * Adoptive Cellular Therapies Workshop

* Registration

* SITC Collaborative Education Programs

* Archive

* Women in Cancer Immunotherapy Network * 2019 WIN Leadership Institute * WIN Leadership Institute Schedule-Chicago * WIN Leadership Institute Schedule-Seattle

* SITC Sparkathon

* Application Details * Matching Donation Challenge

* Business Coaches

* SITC Sparkathon Class of 2017

* Projects

* Team TimIOs

* The METIOR Incubator

* Application

* The METIOR Incubator: Checkpoints Team * The METIOR Incubator: CAR T Cell Team * The METIOR Incubator Mentors * SITC Sparkathon Class of 2018

* Projects

* Team TimIOs

* The METIOR Incubator

* Application

* The METIOR Incubator: Checkpoints Team * The METIOR Incubator: CAR T Cell Team * The METIOR Incubator Mentors * The METIOR Incubator: CAR T Cell Team * 2017 Cohort redirect * Meet-the-Expert Webinars * Certificate in Cancer Immunotherapy * Learner Notification

* Upcoming Events

* SITC Meeting Code of Conduct

* Nursing Resources

* Research

* Journal for ImmunoTherapy of Cancer * New Section Descriptions * Submit a Manuscript * JITC Editorial Board

* JITC Collections

* COVID-19

* Immune Checkpoints Beyond PD-1 * Emerging Immunotherapeutic Agents * Microbial-Based Cancer Immunotherapy * Cancer Immunotherapy Guidelines * Immune Monitoring Technology Primers * Monthly JITC Digest

* 2018

* JITC Digest January 2018 * JITC Digest February 2018 * JITC Digest March 2018 * JITC Digest April 2018 * JITC Digest May 2018 * JITC Digest June 2018 * JITC Digest July 2018 * JITC Digest August 2018 * JITC Digest September 2018 * JITC Digest October 2018 * JITC Digest November 2018 * JITC Digest December 2018

* 2016

* JITC Digest December 2016

* 2017

* JITC Digest August 2017 * JITC Digest September 2017 * JITC Digest October 2017 * JITC Digest July 2017 * JITC Digest June 2017 * JITC Digest May 2017 * JITC Digest April 2017 * JITC Digest March 2017 * JITC Digest February 2017 * JITC Digest January 2017

* 2019

* JITC Digest January 2019 * JITC Digest February 2019 * JITC Digest March 2019 * JITC Digest April 2019 * JITC Digest May 2019 * JITC Digest June 2019 * JITC Digest July 2019 * JITC Digest August 2019 * JITC Digest September 2019 * JITC Digest October 2019 * JITC Digest November 2019 * JITC Digest December 2019

* 2020

* JITC Digest January 2020 * JITC Digest February 2020 * JITC Digest March 2020 * JITC Digest April 2020 * JITC Digest May 2020 * JITC Digest June 2020 * JITC Digest July 2020 * JITC Digest August 2020 * JITC Digest September 2020 * JITC Digest October 2020 * JITC Digest November 2020

* Editors' Picks

* Top Articles of 2017 * JITC's Reading List

* 2019

* February

* March

* April

* May

* June

* July

* August

* September

* October

* November

* December

* 2020

* January

* February

* March

* May

* June

* July

* August

* September

* October

* November

* SITC Cancer Immunotherapy Guidelines * Cutaneous Melanoma * Cutaneous Melanoma - Current Algorithms * Genitourinary Malignancies

* Bladder

* Kidney

* Prostate

* Hematologic Malignancies

* Lung Cancer

* Open Comment Period

* Acute Leukemia

* Head and Neck

* Cancer Immunotherapy Guideline Webinars: Disclosures * CIG Melanoma Webinar: Continuing Education Credits * CIG Head and Neck Webinar: Continuing Education Credits * CIG RCC Webinar: Continuing Education Credits * CIG Lung Webinar: Continuing Education Credits * Cancer Immunotherapy Guideline Webinars: On-Demand

* Multiple Myeloma

* CIG Multiple Myeloma Webinar: Continuing Education Credits

* Lymphoma

* Immune-Related Adverse Events * Immune Effector Cell-Related Adverse Events Guideline

* Immune Biomarkers

* Immunoscore Validation * Immune Responsiveness * Cancer Immunotherapy Principles and Practice Textbook * SITC's Guide to Managing Immunotherapy Toxicity Textbook * COVID-19 Resources

* IL-6 Editorial

* Additional COVID-19 Resources * Open Access to COVID-19 Publications

* Policy & Advocacy

* Archive

* 2015

* 2016

* 2017

* Regulatory Issues

* Standards & Quality of Care * Value of Immunotherapy

* Membership

* Join/Member Benefits * Renew Your Membership * Membership Categories * Corporate Membership

* Members Only

* Volunteer

* Committees

* Cancer Immunotherapy Guidelines Muliple Myeloma Expert Panel * Cancer Immunotherapy Guidelines Non-Small Cell Lung Cancer (NSCLC)

Expert Panel

* Regulatory Subcommittee * International Committee * Science and Research Subcommittee * Early Career Scientist

* Communications

* Industry

* Executive Council

* Annual Program

* Champions

* Immune Biomarkers

* Biomarker Data Sharing Subcommittee * Microbiome Subcommittee * Resources & Useful Tools Subcommittee * Tumor Mutational Burden Subcommittee * Cancer Immunotherapy Guidelines Renal Cell Carcinoma Expert Panel

* Membership

* Quality Subcommittee * Education and Training Committee * Advances in Cancer Immunotherapy™ (ACI) Committee * Cancer Immunotherapy Guidelines Acute Leukemia Expert Panel * Policy and Advocacy Committee

* Bylaws

* Advocacy Subcommittee * Cancer Immunotherapy Guidelines Oversight Committee * Cancer Immunotherapy Guidelines Lymphoma Expert Panel * Cancer Immunotherapy Guidelines Melanoma Expert Panel

* Finance Committee

* Cancer Immunotherapy Guidelines Bladder Carcinoma Expert Panel * Nominating Subcommittee * International Young Investigator Subcommittee * Cancer Immunotherapy Guidelines Prostate Carcinoma Expert Panel

* Awards Review

* Cancer Immunotherapy Guidelines Head and Neck Expert Panel * Immunoscore Steering Committee

* Surgery Committee

* Cancer Immunotherapy Guidelines Immune-Checkpoint Inhibitors-Related Adverse Events * Cancer Immunotherapy Guidelines Immune Effector Cell (IEC)-related Adverse Events Expert Panel * Big Data and Data Sharing Committee * Global Access and Impact Committee * Cancer Immunotherapy Guidelines Breast Expert Panel * Cancer Immunotherapy Guidelines Hepatocellular Expert Panel * Cancer Immunotherapy Guidelines Non Melanoma Skin Cancer Expert

Panel

* Immunotherapy Resistance Committee * Immunoscore Dissemination Committee * Pathology Committee

* SITC Task Forces

* Cancer Immune Responsiveness Task Force * Certification Task Force

* Biomarkers

* Biomarkers Task Force 2009-2012 * Biomarkers Task Force 2014 - present * Immune Monitoring Technology Primer Series * Pathology Task Force * Genitourinary Malignancies Task Force * Immunoscore Steering * Key Information Release

* CTCAE Task Force

* SITC Volunteer Groups * World Immunotherapy Council (WIC) * Connect-a-Colleague * Path to SITC Leadership * 2020 SITC Election * Padmanee Sharma, MD, PhD • 2020 SITC Election * Leisha Emens, MD, PhD • 2020 SITC Election * Sandra Demaria, MD • 2020 SITC Election * Tullia Bruno, PhD • 2020 SITC Election * Christian Capitini, MD • 2020 SITC Election * Karin Jooss, PhD • 2020 SITC Election * Kimberly Shafer-Weaver, PhD • 2020 SITC Election * Ann Silk, MD, MS • 2020 SITC Election * Adekunle Odunsi, MD, PhD, FRCOG, FACOG • 2020 SITC Election * Jedd Wolchok, MD, PhD • 2020 SITC Election

* Funding

* 2020 SITC Supporters

* Support SITC

* SOG 2019

* Faces of the _Forward_ Fund

* Fellowships

* NCI Immunotherapy Fellowship

* FAQ

* Awards

* 2014

* 2015

* 2016

* 2017

* 2018

* 2019

* 2017

* NCI Immunotherapy Fellowship

* Genentech-Kohrt

* Merck

* 2018

* SITC-BMS Translational Fellowship Award * SITC-AstraZeneca Clinical * SITC-Merck Cancer Immunotherapy Clinical Fellowship Award * SITC-SU2C Convergence Scholar Awards * SU2C-SITC Convergence Scholar Award 1 * SU2C-SITC Convergence Scholar Award 2 * SU2C-SITC Convergence Scholar Award 3 * SU2C-SITC Convergence Scholar Award 4

* 2019

* SITC-Amgen Cancer Immunotherapy in Hematologic Malignancies

Fellowship Award

* SITC-AstraZeneca Immunotherapy in Lung Cancer (Early Stage NSCLC) Clinical Fellowship Award * SITCs Holbrook Kohrt, MD, PhD Cancer Immunotherapy Translational Memorial Fellowship Award

* 2020

* SITC-NanoString Technologies Spatial Profiling Award * SITC-BMS Translational Fellowship Award * SITC-Merck Cancer Immunotherapy Clinical Fellowship * SITCs Holbrook Kohrt, MD, PhD Cancer Immunotherapy Translational

Memorial Fellowship

* SITC-Amgen Cancer Immunotherapy in Hematologic Malignancies

Fellowship

* SITC-Genentech Women in Cancer Immunotherapy Fellowship * SITC-AstraZeneca Immunotherapy in Lung Cancer Clinical Fellowship

* Awards

* Richard V. Smalley, MD, Memorial Award and Lectureship * Richard V. Smalley Biography

* 2005

* 2006

* 2007

* 2008

* 2009

* 2010

* 2011

* 2012

* 2013

* 2014

* 2015

* 2016

* 2017

* 2018

* JITC Best Paper Awards

* 2016

* 2015

* 2014

* 2017

* 2018 Year

* 2019

* Presidential Awards * Young Investigator Awards * 2019 International Scholars * 2017 International Scholars * 2015 International Scholars * The CheckPoints Band * Career Connections

* Contact Pop-Up

* About SITC

* Mission & Vision

* Support SITC

* Corporate Opportunities

* Partnerships

* History of SITC

* 1986 - 1991: Early Visions * 1992 - 1998: Finding Our Way * 1999 - 2006: Growth and Prosperity * 2007 - 2009: A New Era * Board of Directors * SITC Board of Directors * Career Connections * Committees, Task Forces and Professional Interest Communities

* SITC Task Forces

* Professional Interest Communities

* SITC Committees

* SITC Cancer Immunotherapy Guidelines Expert Panels

* Media Room

* Cancer Immunotherapy Month

* Media Resources

* Immunotherapy News * Scientific Meeting Highlights from SITC

* 2017

* ESMO 2017

* 2016

* 2015

* 2014

* 2018

* 2019

* AACR Annual Meeting 2019 * ASCO 2019 Meeting Highlights * ESMO Congress 2019 Highlights * 61st ASH Annual Meeting & Exposition Scientific Highlights

* AACR 2018

* ASCO 2018 Meeting Highlights * ASH 2018 Meeting Highlights * ASH 2018 Meeting Highlights - Dec. 1 * ASH 2018 Meeting Highlights - Dec. 2 * ASH 2018 Meeting Highlights - Dec. 3 * ASH 2018 Meeting Highlights - Dec. 4

* 2020

* SITC Staff

* Contact SITC

SITC CANCER IMMUNOTHERAPY CONNECT

BG IMAGE 8 - IW

STAY CONNECTED TO SITC 2020 Review data presented at the 35th Anniversary Annual Meeting & Pre-Conference Programs in the SITC 2020 regular abstract pre-print published in the _Journal for ImmunoTherapy of Cancer (JITC)_! SITC welcomed over 5,200 cancer immunotherapy professionals to SITC 2020 this November, our first ever virtual annual meeting!

LEARN MORE

ATTEND SITC'S ANNUAL CANCER IMMUNOTHERAPY WINTER SCHOOL Taught by leading experts in the field, this program, being held virtually Feb. 22–24, provides a deep understanding of the core principles of tumor immunology and cancer immunotherapy as well as developing areas in the field including biomarker technology, validation and clinical integration; clinical trial design, data analysis and considerations for combination therapies.

REGISTER TODAY

CERTIFICATE IN CANCER IMMUNOTHERAPY: MODULE 2 NOW AVAILABLE In module 2, Basic Cancer Immunotherapy Concepts, participants will cover the biological foundation of cancer immunotherapy, applying the basic immunology concepts learned in module 1 to help lay the foundation for future topics in this program.

LEARN MORE

_JITC_ REVIEW SERIES: IMMUNE CHECKPOINTS BEYOND PD-1 Comprised of several authoritative reviews of checkpoints beyond PD-1, this series, edited by Ana Carrizosa Anderson and Dario A.A. Vignali, promotes the tremendous research that is opening new pathways for treating patients with cancer.

EXPLORE THE SERIES

LOG IN TO

AN UPCOMING ADVANCES IN CANCER IMMUNOTHERAPY™ LIVE VIRTUAL

PROGRAM!

Stay current with FDA-approved immunotherapy treatments INDIANAPOLIS ON DEC. 3 LOUISVILLE, KY., ON DEC. 10 SAN ANTONIO ON DEC. 12

VIEW MORE LOCATIONS

NOW AVAILABLE: SITC CLINICAL PRACTICE GUIDELINE ON IMMUNOTHERAPY FOR THE TREATMENT OF ACUTE LEUKEMIA

READ THE MANUSCRIPT

SITC COVID-19 RESOURCES The Society for Immunotherapy of Cancer (SITC) is committed to providing the most current COVID-19 information and resources to its members and the oncology community at large.

LEARN MORE

WHY _I'M_ A SITC MEMBER Join Brianna Hoffner, MSN, ANP-BC, AOCNP, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC

members.

BECOME A SITC MEMBER New Online Patient Course Available: _Understanding Cancer

Immunotherapy_

Access SITC’s dedicated resource for patients and caregivers to learn about cancer immunotherapy ACCESS PATIENT COURSE Immunotherapy for the Treatment of Breast and Gynecologic Cancers A free, interactive course, part of the Advances in Cancer Immunotherapy™ online education series.

REGISTER NOW

* 1

* 2

* 3

* 4

* 5

* 6

* 7

* 8

* 9

* 10

CONSISTENT WITH THE SAFER AT HOME ORDER ISSUED BY THE DEPARTMENT OF HEALTH SERVICES OF THE STATE OF WISCONSIN, ALL SITC EXECUTIVE OFFICE STAFF WILL BE WORKING REMOTELY BEGINNING MARCH 25 AND ARE BEST REACHED THROUGH EMAIL. GENERAL INQUIRIES CAN BE SENT TO INFO@SITCANCER.ORG. THANK YOU FOR UNDERSTANDING.

PATIENT

Explore resources and educational opportunities for cancer patients and those who advocate for them.

EXPLORE

CLINICIAN

Track the latest advancements and educational opportunities in tumor immunology and cancer immunotherapy.

EXPLORE

RESEARCHER

Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.

EXPLORE

LATEST DISCUSSIONS

*

ABOUT THE COVID-19 PATIENT MANAGEMENT FORUM

By: SITC Education

, 8 months ago

POSTED IN: COVID-19 IMPLICATIONS FOR I-O PATIENT MANAGEMENT Purpose: Conversations directly relevant to patient care Audience: Practicing clinicians and staff, clinical investigators Suggested topics: demographics, clinical presentation, diagnostic testing, patient management issues/insights, patterns in ... 3 people recommend this.

Ranju Gupta

Lehigh Valley Health Network

William Lavietes

Carolina Asthma & Allergy

Hoyoung Maeng

National Cancer Institute

*

ABOUT THE COVID-19 BASIC AND TRANSLATIONAL RESEARCH ...

By: SITC Education

, 8 months ago

POSTED IN: COVID-19 CONSIDERATIONS FOR BASIC AND TRANSLATIONAL

RESEARCH

Purpose: Conversations directly relevant to research Audience: Laboratory and translational scientists Suggested topics: Data sharing, emerging literature, sample/tissue collection, model/reagent development, opportunities for collaboration, translational ... 1 person recommends this.

Hoyoung Maeng

National Cancer Institute

*

VIRTUAL | 9TH ANNUAL LUNG CANCER SYMPOISUM | REGISTER ...

By: Jefferson CME

, 13 days ago

POSTED IN: CANCER IMMUNOTHERAPY CONNECT OPEN FORUM 9th Annual Lung Cancer Symposium - Virtual Meeting March 4-5, 2021 https://cme.jefferson.edu/content/lung2021 The 9th Annual Lung Cancer Symposium will offer attendees the opportunity for a comprehensive update in lung cancer while interacting ... Read More Discussions FOLLOW THE SITC TWITTER FEED.

POWERED BY JUICER

*

SITC

@sitcancerTwitter Logo Enduring materials from the 2018-19 ACI Series are now open. These materials will strengthen your understanding of the tumor immunology and cancer immunotherapy topics covered during the live session. Access or purchase the enduring materials by visiting sitcancer.org/education/aci/…

* Reply

* Retweet

* Like

17 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Case Report: PD-L1 detection using 89Zr-atezolizumab immuno-PET in renal cell carcinoma tumorgrafts from a patient with favorable nivolumab response jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

17 Jun 2019

*

SITC

@sitcancerTwitter Logo Just Announced for SITC 2019-Novel Multi-Targeted Therapeutic Platforms! For updated session, speaker and presentation information on this and all of #SITC2019 's great programs, please visit sitcancer.org/2019/home .

* Reply

* Retweet

* Like

17 Jun 2019

*

SITC

@sitcancerTwitter Logo SITC's 2019 Interactive Course: Genitourinary Cancer and Immunotherapy gives an overview of the mechanisms by which the immune system eliminates foreign pathogens and cancer cells. To register for this online course to take it on your schedule, click here: connected.sitcancer.org/store/seminar/…

* Reply

* Retweet

* Like

17 Jun 2019

*

SITC

@sitcancerTwitter Logo TOMORROW! We are presenting a course with @FOCISimmunology at their annual meeting titled: Cancer Immunity & Immunotherapy. It reviews tumor immunoloy as the scientific foundation for cancer immunotherapy. See you in Boston! sitcancer.org/events/event-d…

* Reply

* Retweet

* Like

17 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Research: CD45RA+CCR7− CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

17 Jun 2019

*

SITC

@sitcancerTwitter Logo Our Grant Writing Workshop, held at #SITC2019 , offers unique insight into the grant submission process through an interactive “mini-study section,” allowing attendees to experience how a study section evaluates a grant proposal. #Immune2Cancer

#WearWhite

sitcancer.org/2019/program/p…

* Reply

* Retweet

* Like

17 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Research: Opportunities and challenges of active immunotherapy in dogs with B-cell lymphoma: a 5-year experience in two veterinary oncology centers jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

16 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Commentary: Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

16 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Research: Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

16 Jun 2019

*

JUICER

Juicer.io lets you easily create and embed social media feeds like this one on to your site for free!

*

SITC

@sitcancerTwitter Logo AVAILABLE NOW: SITC's Guide to Managing Immunotherapy Toxicity Textbook, a handbook providing thorough coverage of the toxicity and management of adverse events for immune checkpoint inhibitors. Save 20% & receive free shipping with code: ESITC20 sitcancer.org/toxicitybook

* Reply

* Retweet

* Like

16 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Research: Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

15 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Review: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

15 Jun 2019

*

SITC

@sitcancerTwitter Logo Enduring materials from the 2019 SITC Cancer Immunotherapy Winter School are now open access to the public. Access these enduring materials by visiting sitcancer.org/winterschool

* Reply

* Retweet

* Like

15 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Case Report: Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors? jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

15 Jun 2019

*

Fight Colorectal Cancer @FightCRCTwitter Logo Retweeted by SITC We are dedicated to educating our community about #immunotherapy options & working to advance science with leading experts, patient advocates, and other organizations. Be sure to check out some of the resources @sitcancer offers! #ImmunotherapyMonth fightcolorectalcancer.org/fight/library/…

* Reply

* Retweet

* Like

15 Jun 2019

*

SITC

@sitcancerTwitter Logo At #SITC2019 's Workshop on Intratumoral Immunomodulation, the current state of intratumoral immunomodulation will be presented. The future direction for the field and implications for immunotherapy treatments will also be covered.

#Immune2Cancer

#WearWhite

sitcancer.org/2019/program/p…

* Reply

* Retweet

* Like

15 Jun 2019

*

SITC

@sitcancerTwitter Logo New #JITC Short Report: B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

15 Jun 2019

*

SITC

@sitcancerTwitter Logo New #JITC Research: PD-1 signaling affects cristae morphology and leads to mitochondrial dysfunction in human CD8+ T lymphocytes jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

14 Jun 2019

*

JUICER

Engage your users on social media with a Juicer.io feed on your website or blog for

free.

*

Victoria L Chiou MD

@VLChiouMDTwitter Logo Retweeted by SITC Excited to work together towards a future #Immune2Cancer

with incredible

research leaders @sitcancer and Women in Cancer #Immunotherapy Network ! #WomenInSTEM

#WearWhite

🥼

* Reply

* Retweet

* Like

14 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Research: Level of neo-epitope predecessor and mutation type determine T cell activation of MHC binding peptides jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

14 Jun 2019

*

SITC

@sitcancerTwitter Logo New #JITC Research: Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNγ receptor signaling jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

14 Jun 2019

*

SITC

@sitcancerTwitter Logo Replying to @BernardAFox

@BernardAFox

@theNCI

@FDAOncology @CancerResearch

@KomenOregon

@ChilesResearch

@ProvHealth

@KuniFoundation

Thank you for all that you do for SITC and your contributions in the field of cancer immunotherapy!

* Reply

* Retweet

* Like

14 Jun 2019

*

Bernard A Fox

@BernardAFoxTwitter Logo Retweeted by SITC We #WearWhite

for a future

#Immune2Cancer /Will take Patients, Families, Docs, Scientists, Staff, @theNCI

@FDAOncology

, #biotech

#pharma

, Advocates & Donors to

#FinishCancer

#cancerimmunotherapy

@sitcancer

@CancerResearch

@KomenOregon

@ChilesResearch

@ProvHealth

@KuniFoundation

* Reply

* Retweet

* Like

14 Jun 2019

*

SITC

@sitcancerTwitter Logo Replying to @KathleenKokolus

@KathleenKokolus

@RoswellPark

@CancerResearch

@NCIResearchCtr

Thank you for your support and for all you do to advance the field of cancer immunotherapy!

* Reply

* Retweet

* Like

14 Jun 2019

*

Kathleen Kokolus, PhD @KathleenKokolusTwitter Logo Retweeted by SITC Translational Research at @RoswellPark is representing #Immunotherapy ! Today we #WearWhite

to support all the

patients, clinicians and scientists working together to create a future #Immune2Cancer ! @CancerResearch @sitcancer

@NCIResearchCtr

#ImmunotherapySavesLives

#CIM19

* Reply

* Retweet

* Like

14 Jun 2019

*

Mark Rice

@Envirominer3Twitter Logo Replying to @DanKomaromi Retweeted by SITC @DanKomaromi

@uretericbud

@nature

Exciting recommendation, this @sitcancer presentation poster recognized Gal-3 inhibitor GR-MD-02 prolonged survival in TRAMP-C1 #ProstateCancer model in addition to

#breastcancer &

#lungcancer models. Amazing work by @ChilesResearch @ProvHealth #PlaidforDad

* Reply

* Retweet

* Like

14 Jun 2019

*

SITC

@sitcancerTwitter Logo Replying to @SMImmunology

@SMImmunology

@CancerResearch

@WesternU_CTCR

@RicardoOnco

@el_mikal

@SchulichMedDent

@LHSCCanada

Thank you @SMImmunology for being such an engaged member with SITC! We look forward to the progress you continue to make in the

field.

* Reply

* Retweet

* Like

14 Jun 2019

*

JUICER

Juicer.io lets you easily create and embed social media feeds like this one on to your site for free!

*

Saman Maleki, PhD

@SMImmunologyTwitter Logo Retweeted by SITC #WeTheNorth

#wearwhite

b/c we believe with

#cancerimmunotherapy

we can help

patients with late-stage #cancers & our research will help to

#finishcancer

@CancerResearch @sitcancer

@WesternU_CTCR

@RicardoOnco

@el_mikal

@SchulichMedDent

@LHSCCanada

* Reply

* Retweet

* Like

14 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Research: Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

14 Jun 2019

*

SITC

@sitcancerTwitter Logo Here is a direct link to SITC's #WearWhite flyer. Take a selfie sharing why YOU wear white. higherlogicdownload.s3.amazonaws.com/SITCANCER/2c19… #CancerImmunotherapy

#MakingCureaReality

#CancerResearch

* Reply

* Retweet

* Like

14 Jun 2019

*

SITC

@sitcancerTwitter Logo SITC staff are proud to #WearWhite today as we honor the researchers, clinicians, patients and many others who are working to advance the science and application of cancer immunotherapy. Download our flyer, take a selfie and share why you #WearWhite

today.

sitcancer.org/aboutsitc/medi…

* Reply

* Retweet

* Like

14 Jun 2019

*

SITC

@sitcancerTwitter Logo Replying to @jasonlukemd

@jasonlukemd

@CancerResearch

@PittTweet

@UPMCHillmanCC

@EmensLeisha

@Vignali_Lab

@DelgoffeLab

@diwakardavar

@RobertFerrisMD

@Pitt_PMI

@UPMC

@UPMCnews Thank you for all that you do for SITC and the field!

* Reply

* Retweet

* Like

14 Jun 2019

*

Jason Luke, MD, FACP @jasonlukemdTwitter Logo Retweeted by SITC I #WearWhite

to support Cancer

#Immunotherapy Month & @CancerResearch @sitcancer . Excited to move my Fam today @PittTweet to lead the Cancer Immunotherapeutics Center @UPMCHillmanCC

w @EmensLeisha

@Vignali_Lab

@DelgoffeLab

@diwakardavar

@RobertFerrisMD

& all @Pitt_PMI

research!

* Reply

* Retweet

* Like

14 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Research: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

14 Jun 2019

*

Dan Chen

@DanChenMDPhDTwitter Logo Replying to @sitcancerECS Retweeted by SITC @sitcancerECS

@gulleyj1

@DrK4CINJ

@sitcancer

Few things will contribute more to the advancement of cancer immunotherapy as helping train and support the scientists and investigators of tomorrow. Thanks #SITC

!

* Reply

* Retweet

* Like

14 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Short Report: Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

13 Jun 2019

*

JUICER

Juicer.io lets you easily create and embed social media feeds like this one on to your site for free!

*

SITC

@sitcancerTwitter Logo During #SITC2019 's Workshop on Intratumoral Immunomodulation, the current status of intratumoral immunomodulation will be presented and future directions for the field will be discussed, along with implications for immunotherapy treatments. Learn more: sitcancer.org/2019/program/p…

* Reply

* Retweet

* Like

13 Jun 2019

*

SITC

@sitcancerTwitter Logo Register now for SITC's upcoming interim workshops on Sept. 4-6, 2019,

in #Houston !

Cancer Immune Responsiveness Workshop: sitcancer.org/education/cirw… Adoptive Cellular Therapies Workshop: sitcancer.org/education/actw…

* Reply

* Retweet

* Like

13 Jun 2019

*

SITC Early Career Scientist Committee @sitcancerECSTwitter Logo Retweeted by SITC Our Committee was so pleased to host an ECS #Networking Event earlier this month in #Chicago . Thank you Drs. Gulley (@gulleyj1 ), Kaufman (@DrK4CINJ ), Chen (@DanChenMDPhD ) & Grossmann of the @sitcancer Leadership & the Immediate Past President Dr. Butterfield for joining us!

* Reply

* Retweet

* Like

13 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Research: Discovery of a novel natural killer cell line with distinct immunostimulatory and proliferative potential as an alternative platform for cancer immunotherapy jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

13 Jun 2019

*

Saman Maleki, PhD

@SMImmunologyTwitter Logo Retweeted by SITC Introducing @sitcancer @sitcancerECS "Early Career Scientist Committee Twitter account". I'm pleased to serve on this committee with a group of amazing early-career scientists and clinician scientists who study

#immunotherapy

@JennGuerriero @MarcoRuella

@CVanpouilleBox

twitter.com/sitcancerECS/s…

* Reply

* Retweet

* Like

12 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Research: Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

12 Jun 2019

*

SITC

@sitcancerTwitter Logo We will conduct a joint KCA-SITC Translational Immunotherapy session at the KCA Annual Meeting in Seoul, South Korea from June 20-21. This session will provide education on novel translational immunotherapy research. Register today! sitcancer.org/events/event-d…

* Reply

* Retweet

* Like

12 Jun 2019

*

SITC

@sitcancerTwitter Logo We facilitate rapid development and global dissemination of cancer immunotherapies through scientific exchange through programs like our World Immunotherapy Council’s 3rd Young Investigator Symposium (taking place at #SITC2019

). #Immune2Cancer

#WearWhite

sitcancer.org/2019/program/p…

* Reply

* Retweet

* Like

12 Jun 2019

*

Jason Luke, MD, FACP @jasonlukemdTwitter Logo Retweeted by SITC Beautiful artistic interpretation of #ASCO19

by Goldberg

kpgoldberg.com/illustration in

@TheCancerLetter

cancerletter.com/articles/20190… Thanks for highlighting @sitcancer #CheckPoints & $ raised to support #immunotherapy

trainees & IO

#research . See you @

#SITC19 !

sitcancer.org/2019/home

* Reply

* Retweet

* Like

12 Jun 2019

*

JUICER

This feed is Powered by Juicer.io

*

SITC

* Reply

* Retweet

* Like

11 Jun 2019

*

SITC

@sitcancerTwitter Logo #SITC2019 's 3rd Young Investigator Symposium provides the opportunity for young scientists and future worldwide leaders to interact through scientific exchange. Learn more about this great program and view updated session and scheduling information at: sitcancer.org/2019/home

* Reply

* Retweet

* Like

11 Jun 2019

*

SITC

@sitcancerTwitter Logo New #JITC Research: Temporal changes within the (bladder) tumor microenvironment that accompany the therapeutic effects of the immunocytokine NHS-IL12 jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

11 Jun 2019

*

SITC

@sitcancerTwitter Logo FDA approved pembrolizumab for the first-line treatment of patients with metastatic or unresectable recurrent head and neck squamous cell carcinoma (HNSCC). MORE: sitcancer.org/Go.aspx?Micros…

* Reply

* Retweet

* Like

11 Jun 2019

*

SITC

* Reply

* Retweet

* Like

11 Jun 2019

*

SITC

@sitcancerTwitter Logo We bring virtual education and accreditation to your cancer team with a series of free, interactive online courses building from our ACI program. They help keep your team current on immunotherapy issues on their own time. #Immune2Cancer

#WearWhite

sitcancer.org/education/aci/…

* Reply

* Retweet

* Like

11 Jun 2019

*

SITC

@sitcancerTwitter Logo #SITC2019 's Grant Writing Workshop offers a complete overview of the grant submission process and a “mini-study section,” letting you experience a study section’s proposal evaluation. Learn more about this program and other great #SITC2019 sessions here: sitcancer.org/2019/home

* Reply

* Retweet

* Like

10 Jun 2019

*

SITC

@sitcancerTwitter Logo FDA granted accelerated approval to polatuzumab vedotin-piiq for adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). MORE: sitcancer.org/aboutsitc/pres…

* Reply

* Retweet

* Like

10 Jun 2019

*

SITC

@sitcancerTwitter Logo The SITC Cancer Immune Responsiveness Workshop, Sept. 4-5 in #Houston , will help you stay at the forefront of emerging technologies, create lasting clinical impact and improved patient care with immunotherapy. Register to attend the workshop today at sitcancer.org/cirworkshop

* Reply

* Retweet

* Like

10 Jun 2019

*

JUICER

Engage your users on social media with a Juicer.io feed on your website or blog for

free.

*

SITC

@sitcancerTwitter Logo #JITC Position Article and Guidelines: The promise of Immuno-oncology: implications for defining the value of cancer treatment jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

10 Jun 2019

*

SITC

@sitcancerTwitter Logo New #JITC Research: CD45RA+CCR7− CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

10 Jun 2019

*

SITC

@sitcancerTwitter Logo On May 17, SITC partnered with @ACCCBuzz on a Policy Summit, hosting stakeholders within cancer immunotherapy, including academia, industry, community oncology & patient advocacy groups, to prioritize and define I-O related issues for policy makers. #CancerImmunotherapyMonth

* Reply

* Retweet

* Like

10 Jun 2019

*

SITC

* Reply

* Retweet

* Like

9 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Research: Level of neo-epitope predecessor and mutation type determine T cell activation of MHC binding peptides jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

9 Jun 2019

*

SITC

* Reply

* Retweet

* Like

9 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Research: Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

8 Jun 2019

*

SITC

* Reply

* Retweet

* Like

8 Jun 2019

*

SITC

* Reply

* Retweet

* Like

8 Jun 2019

*

JUICER

Like this feed? Want one of your own? Visit Juicer.io to get your own free social

media feed!

*

SITC

@sitcancerTwitter Logo The Connect-a-Colleague tool allows SITC members to refer a colleague for SITC membership. The SITC member with the most referrals each year is honored at the society’s Annual Meeting in November. Connect-a-Colleague today at sitcancer.org/membership/con…

* Reply

* Retweet

* Like

8 Jun 2019

*

SITC

@sitcancerTwitter Logo New #JITC Research: DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

8 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Research: Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

8 Jun 2019

*

SITC

@sitcancerTwitter Logo New #JITC Research: Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

7 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Research: Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

7 Jun 2019

*

SITC

@sitcancerTwitter Logo The @Brewers are spreading

#KindnessInMKE and

stopped by the SITC office to make a generous donation! Thank you for supporting the Forward Fund and helping SITC advance the science and application of cancer immunotherapy. #MakingCureaReality

* Reply

* Retweet

* Like

7 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Research: Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

7 Jun 2019

*

SITC

@sitcancerTwitter Logo New #JITC Research: Opportunities and challenges of active immunotherapy in dogs with B-cell lymphoma: a 5-year experience in two veterinary oncology centers jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

7 Jun 2019

*

SITC

@sitcancerTwitter Logo Professional Interest Communities allow SITC members of similar professional disciplines to discuss research, career development topics, help others address professional hurdles and more! Learn more and join a community at sitcancer.org/aboutsitc/get-…

* Reply

* Retweet

* Like

7 Jun 2019

*

JUICER

Juicer.io lets you easily create and embed social media feeds like this one on to your site for free!

*

SITC

* Reply

* Retweet

* Like

7 Jun 2019

*

Karthik Varanasi

@karthik_varanasTwitter Logo Retweeted by SITC Congratulations Vic!!! twitter.com/sitcancer/stat…

* Reply

* Retweet

* Like

7 Jun 2019

*

SITC

@sitcancerTwitter Logo Become a SITC member and gain access to member-exclusive opportunities to serve as faculty at SITC programs through the SITC Volunteer

Portal.

Join SITC today at sitcancer.org/membership/join

* Reply

* Retweet

* Like

6 Jun 2019

*

NCI CCR Med Onc Service @NCICCR_MOSTwitter Logo Replying to @sitcancer Retweeted by SITC @sitcancer

@NIH

@AstraZeneca So proud of @ChenZhao2011 who was awarded this Fellowship Award! Looking forward to seeing the the science. @NCIResearchCtr @NCICCR_MOS

* Reply

* Retweet

* Like

6 Jun 2019

*

James L Gulley MDPhD @gulleyj1Twitter Logo Retweeted by SITC So proud of our

@NIH #Hematology

#Oncology

Fellow who was awarded this Fellowship Award! @theNCI @NCIResearchCtr

@NCICCR_MOS

twitter.com/sitcancer/stat…

* Reply

* Retweet

* Like

6 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Short Report: A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

6 Jun 2019

*

SITC

@sitcancerTwitter Logo New #JITC Short Report: Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

6 Jun 2019

*

SITC

@sitcancerTwitter Logo General registration for the 34th Annual Meeting & Pre-Conference Programs (#SITC2019 ) is now open. Register to learn why SITC 2019 is the leading destination for scientific exchange, education and networking in the cancer immunotherapy field. sitcancer.org/2019/home

#SITC2019

* Reply

* Retweet

* Like

6 Jun 2019

*

SITC

* Reply

* Retweet

* Like

6 Jun 2019

*

JUICER

Engage your users on social media with a Juicer.io feed on your website or blog for

free.

*

SITC

@sitcancerTwitter Logo THIS WEEKEND! We will be at the @SIO_Central Annual Meeting in Boston, collaborating with SIO on a session titled: SITC Meets SIO: An Introduction to Immunotherapy. Register here: sitcancer.org/events/event-d… …

#MakingCureaReality

* Reply

* Retweet

* Like

6 Jun 2019

*

Kate Lurain

@DrKateLurainTwitter Logo Retweeted by SITC Our fellows are awesome. Congrats Dr. Zhao! @NCIResearchCtr

@theNCI

twitter.com/sitcancer/stat…

* Reply

* Retweet

* Like

6 Jun 2019

*

Lekha Mikkilineni

@LMikkMDTwitter Logo Retweeted by SITC Congrats to my amazing colleague at the NIH!!!! twitter.com/sitcancer/stat…

* Reply

* Retweet

* Like

6 Jun 2019

*

Chen Zhao

@ChenZhao2011Twitter Logo Replying to @sitcancer Retweeted by SITC @sitcancer

@NIH

@AstraZeneca Thank you very much @sitcancer ! I am extremely honored to receive this award. We are looking forward to exploring lung microbiota in NSCLC with support from @NCIResearchCtr

@NIAIDNews

@nhlbi

@NCIBillDahut @gulleyj1

@mbilusic

!#microbiome

#LungCancer

#Germliner

* Reply

* Retweet

* Like

6 Jun 2019

*

SITC

@sitcancerTwitter Logo Congratulations to Dr. Chen Zhao of @NIH , recipient of the 2019 SITC-@AstraZeneca Immunotherapy in Lung Cancer (Early Stage NSCLC) Clinical Fellowship Award, a 1-year, $100K SITC Fellowship! sitcancer.org/aboutsitc/pres…

* Reply

* Retweet

* Like

6 Jun 2019

*

SITC

@sitcancerTwitter Logo Congratulations to Dr. May Daher of @MDAndersonNews , recipient of the 2019 SITC-@Amgen Cancer Immunotherapy in Hematologic Malignancies Fellowship Award, a 1-year, $100K SITC Fellowship! sitcancer.org/aboutsitc/pres…

* Reply

* Retweet

* Like

6 Jun 2019

*

SITC

@sitcancerTwitter Logo Congratulations to Dr. Yimin (Victor) Du of @salkinstitute , recipient of the 2019 SITC's Holbrook Kohrt, MD, PhD Cancer Immunotherapy Translational Memorial Fellowship Award (sponsored by @genentech ), a 1-year, $100K SITC Fellowship! sitcancer.org/aboutsitc/pres…

* Reply

* Retweet

* Like

6 Jun 2019

*

SITC

@sitcancerTwitter Logo NEWS RELEASE: SITC Announces Recipients of 2019 Postdoctoral Cancer Immunotherapy Fellowship Awards sitcancer.org/aboutsitc/pres…

* Reply

* Retweet

* Like

6 Jun 2019

*

SITC

@sitcancerTwitter Logo SITC, in collaboration with @CancerResrch , developed for the general public 4 value fact sheets outlining the pathways of immuno-oncology and the unique benefits such treatments provide compared to others. Learn more at sitcancer.org/advocacy

* Reply

* Retweet

* Like

6 Jun 2019

*

JUICER

Like this feed? Want one of your own? Visit Juicer.io to get your own free social

media feed!

*

SITC

* Reply

* Retweet

* Like

5 Jun 2019

*

SITC

@sitcancerTwitter Logo Growing to more than 2,400 members in 2018, SITC is the world’s leading member-driven society dedicated to professionals working in the cancer immunotherapy field. Join SITC today and help us make the word “cure” a reality for cancer patients everywhere. sitcancer.org/membership/join

* Reply

* Retweet

* Like

5 Jun 2019

*

SITC

@sitcancerTwitter Logo Join SITC for a pair of back-to-back immuno-oncology workshops Sept. 4-6 in Houston focused on cancer immune responsiveness and adoptive cellular therapies. Watch our new video and then register to attend today: youtube.com/watch?v=jZvyy6…

* Reply

* Retweet

* Like

5 Jun 2019

*

SITC

@sitcancerTwitter Logo We are presenting a course with @FOCISimmunology on June 18 at their annual meeting titled: Cancer Immunity & Immunotherapy. It reviews tumor immunoloy as the scientific foundation for cancer immunotherapy. For a registration discount, please email SITC at education@sitcancer.org

* Reply

* Retweet

* Like

5 Jun 2019

*

SITC

* Reply

* Retweet

* Like

5 Jun 2019

*

SITC

@sitcancerTwitter Logo In his June President’s Message, SITC President Dr. Mario Sznol shares how SITC is honoring and celebrating Cancer Immunotherapy Awareness Month™ and how you can support the society and #CancerImmunotherapy

research on June

14 for #WearWhite Day blog.sitcancer.org/2019/06/presid…

* Reply

* Retweet

* Like

4 Jun 2019

*

SITC

@sitcancerTwitter Logo The SITC Volunteer Portal provides SITC members with exclusive access to numerous volunteer opportunities within the society, including serving as faculty scientific correspondent and more. Join the volunteer pool today at sitcancer.org/membership/vol…

* Reply

* Retweet

* Like

4 Jun 2019

*

SITC

@sitcancerTwitter Logo New #JITC Case Report: PD-L1 detection using 89Zr-atezolizumab immuno-PET in renal cell carcinoma tumorgrafts from a patient with favorable nivolumab response jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

4 Jun 2019

*

SITC

@sitcancerTwitter Logo #JITC Position Article and Guidelines: The promise of Immuno-oncology: implications for defining the value of cancer treatment jitc.biomedcentral.com/articles/10.11…

* Reply

* Retweet

* Like

4 Jun 2019

Load More

*

Monday

7 December

MEET-THE-EXPERT WEBINAR SERIES: CAREERS IN GOVERNMENT Dec 7, 2:00 PM - 3:00 PM (ET)

*

Tuesday

8 December

LIVE VIRTUAL TORONTO ADVANCES IN CANCER IMMUNOTHERAPY™️ PROGRAM Dec 8, 3:30 PM - 8:20 PM (ET)

*

Wednesday

9 December

SITC PRIMER ON CANCER IMMUNOTHERAPY AT ESMO-IO CONGRESS

Dec 9 - 12, (CET)

*

Thursday

10 December

LIVE VIRTUAL LOUISVILLE ADVANCES IN CANCER IMMUNOTHERAPY™️

PROGRAM

Dec 10, 3:00 PM - 8:30 PM (ET)

Explore More Events

IGNITE THE SITC SPARKATHON DONATE TODAY to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.

LEARN MORE

THE JOURNAL & THE BLOG _JOURNAL FOR IMMUNOTHERAPY OF CANCER_ An open access, peer-reviewed journal, the _Journal for ImmunoTherapy of Cancer (JITC)_ is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

LEARN MORE

*

JITC LETTER FROM THE EDITOR- NOVEMBER 2020

8 days ago

Details

Image Url

HTML Url

Moderation By

More Annotations

Danielle Fletcher

2020-04-12 21:33:01

Danielle Fletcher

2020-04-12 21:34:31

Danielle Fletcher

2020-04-12 21:35:45

Danielle Fletcher

2020-04-12 21:36:24

Danielle Fletcher

2020-04-12 21:36:48

Danielle Fletcher

2020-04-12 21:37:04

Danielle Fletcher

2020-04-12 21:37:32

Danielle Fletcher

2020-04-12 21:37:41

Danielle Fletcher

2020-04-12 21:37:55

Danielle Fletcher

2020-04-12 21:38:19

Danielle Fletcher

2020-04-12 21:38:38

Danielle Fletcher

2020-04-12 21:38:53

Favourite Annotations

Danielle Fletcher

2021-06-05 14:06:41

Danielle Fletcher

2021-06-05 14:06:42

Danielle Fletcher

2021-06-05 14:06:42

Danielle Fletcher

2021-06-05 14:06:42

Danielle Fletcher

2021-06-05 14:06:43

Danielle Fletcher

2021-06-05 14:06:44

Danielle Fletcher

2021-06-05 14:06:44

Danielle Fletcher

2021-06-05 14:06:44

Danielle Fletcher

2021-06-05 14:06:44

Danielle Fletcher

2021-06-05 14:06:47

Danielle Fletcher

2021-06-05 14:06:48

Danielle Fletcher

2021-06-05 14:06:48

Text

HOME - SITC 2021

REGISTRATION

$25.00.

HOME - SITC 2021

REGISTRATION

$25.00.

$25.00.

UPCOMING EVENTS

VIRTUAL HAPPY HOUR

HOME - SITC 2021

REGISTRATION

HOME - SITC 2021

REGISTRATION

UPCOMING EVENTS

SPONSORED SYMPOSIA

the Society.

UPCOMING WEBINARS

HOME - SITC 2021

REGISTRATION

HOME - SITC 2021

REGISTRATION

UPCOMING EVENTS

SPONSORED SYMPOSIA

the Society.

UPCOMING WEBINARS

HOME - SITC 2021

REGISTRATION

SITC 2018

consider